ArticleCureus2025
Clinico-Epidemiological Study of Facial Dermatoses.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFacial dermatoses constitute a diverse group of skin conditions that can significantly impact patients' quality of life due to the cosmetic and psychological implications. Understanding the clinico-epidemiological patterns of these conditions aids in timely diagnosis and effective management.
objectiveThis study aims to determine the clinical and epidemiological profile of patients presenting with facial dermatoses in a tertiary care dermatology outpatient setting. MATERIALS AND
methodsA descriptive cross-sectional study was conducted in the Department of Dermatology, Venereology, and Leprology of a tertiary care hospital over 18 months (April 2023 to September 2024). Four hundred patients (n=400) of all ages and both sexes presenting with facial dermatoses were enrolled consecutively. A structured pro forma was used to collect demographic and clinical data. Relevant investigations, such as potassium hydroxide mount, Wood's lamp examination, and skin biopsy, were performed as indicated. Data were analyzed using Epi Info v3.4.5 and 7.1.5 (U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA).
resultsOut of 400 patients, 242 (60.5%) were females and 158 (39.5%) were males. The most affected age group was 21-30 years, comprising 114 (28.5%) patients. Pigmentary disorders were the most common category, observed in 123 (30.8%) patients, with melasma being the leading condition, affecting 82 (20.5%) patients. Infectious dermatoses were seen in 95 (23.8%) cases, with tinea faciei being the most frequent, affecting 42 (10.5%) patients. Acne vulgaris was present in 65 (16.3%) patients, and eczema in 48 (12%) patients. A significant association was found between pigmentary dermatoses and female gender (p<0.05). Seasonal variation and history of prior treatment were noted in a considerable number of patients, accounting for 176 (44%) and 139 (34.8%) cases, respectively.
conclusionsFacial dermatoses are more prevalent in young adults and females, with pigmentary disorders, infections, and acne being the most frequent presentations. The findings underscore the importance of public awareness, early intervention, and further research to investigate risk factors and develop effective preventive strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.